National Comprehensive Cancer Network



About NCCN

NCCN Establishes Second Policy and Advocacy Fellowship

NCCN’s second policy and advocacy fellow will maintain a comprehensive understanding of the oncology policy landscape, contribute to the advancement of NCCN’s policy initiatives, and contribute to the monitoring and awareness of use of NCCN Content by public and private payers to enhance access to and delivery of quality oncology care in the United States.

(FORT WASHINGTON, PA – January 26, 2017) The National Comprehensive Cancer Network® (NCCN®) has instituted its second Policy and Advocacy Fellowship to support access to and delivery of high-quality cancer care throughout the United States. NCCN established its first Policy and Advocacy Fellowship in May 2016.

The NCCN Policy and Advocacy Fellowship provides exposure to oncology policy topics and related skills in the early stages of their career. Among various responsibilities, the Policy/Advocacy Fellow will track legislative activities that could affect access to quality cancer care, contribute to the advancement of NCCN’s policy initiatives, and contribute to the monitoring of use of NCCN Content by public and private payers and health information technology innovators to support access to high-quality cancer care.

“NCCN is proud to establish a second Policy/Advocacy Fellowship to work on behalf of patients with public and private payers and employers, as well as other initiatives in this time of rapid health care policy change and development,” said Robert W. Carlson, MD, Chief Executive Officer, NCCN.

NCCN Policy fellows learn techniques in policy research, development, advocacy, communication, and implementation of oncology policy programs that further NCCN’s mission to improve the quality, effectiveness, and efficiency of cancer care so that patients can live better lives.

The NCCN Policy/Advocacy Fellowship is supported by Celgene, Gilead Sciences, Taiho Oncology, an educational donation provided by Amgen, and an independent educational grant from Merck & Co., Inc.

For more information about the NCCN Oncology Policy Program, visit NCCN.org/policy.

###

 

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit NCCN.org.

The NCCN Member Institutions are:

  • Abramson Cancer Center at the University of Pennsylvania
  • Fred & Pamela Buffett Cancer Center
  • Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
  • City of Hope National Medical Center
  • Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center
  • Duke Cancer Institute
  • Fox Chase Cancer Center
  • Huntsman Cancer Institute at the University of Utah
  • Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Mayo Clinic Cancer Center
  • Memorial Sloan Kettering Cancer Center
  • Moffitt Cancer Center
  • The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
  • Roswell Park Comprehensive Cancer Center
  • Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
  • St. Jude Children's Research Hospital/The University of Tennessee Health Science Center
  • Stanford Cancer Institute
  • University of Alabama at Birmingham Comprehensive Cancer Center
  • UC San Diego Moores Cancer Center
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • University of Colorado Cancer Center
  • University of Michigan Rogel Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • University of Wisconsin Carbone Cancer Center
  • Vanderbilt-Ingram Cancer Center
  • Yale Cancer Center/Smilow Cancer Hospital